1. The roles, molecular interactions, and therapeutic value of CDK16 in human cancers
   Xiao Wang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
2. Circulating cell‐free microRNAs in cutaneous melanoma staging and recurrence or survival prognosis
   Beatrice Polini et al, 2019, Pigment Cell & Melanoma Research CrossRef
3. MiR-211 is epigenetically regulated by DNMT1 mediated methylation and inhibits EMT of melanoma cells by targeting RAB22A
   Haizhou Yu et al, 2016, Biochemical and Biophysical Research Communications CrossRef
4. Role of microRNA‑33a in malignant cells (Review)
   Chang Gao et al, 2020, Oncology Letters CrossRef
5. Pathophysiology roles and translational opportunities of miRNAs in cutaneous melanoma
   Manuela Ferracin et al, 2022, MicroRNA in Human Malignancies CrossRef
6. miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
   Nathan L Price et al, 2021, EMBO Molecular Medicine CrossRef
7. Non-coding RNAs in lipid metabolism
   Xinbo Zhang et al, 2019, Vascular Pharmacology CrossRef
8. miR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling
   You-Jie Li et al, 2018, International Journal of Oncology CrossRef
9. MicroRNA-33a negatively regulates myoblast proliferation by targeting IGF1, follistatin and cyclin D1
   Xinxin Li et al, 2020, Bioscience Reports CrossRef
10. miR‐33a inhibits cell growth in renal cancer by downregulation of MDM4 expression
    Kehua Jiang et al, 2019, Molecular Genetics & Genomic Medicine CrossRef
11. MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets
    Soudeh Ghafouri-Fard et al, 2021, Frontiers in Oncology CrossRef
12. miR-498 Targets UBE2T to Inhibit the Proliferation of Malignant Melanoma Cells
    Wen Cao et al, 2022, Technology in Cancer Research & Treatment CrossRef
13. The Functional Role of Long Non-Coding RNAs in Melanoma
    Michal Wozniak et al, 2021, Cancers CrossRef